Cookies on the
LGC website
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on the LGC website. However, if you would like to, you can change your cookie settings at anytime.
Question markFind out more

NeuroMET mini symposium July 2017

13 Oct 2017
The first NeuroMET mini symposium was held at RI.SE, Göteborg, Sweden, as a satellite event to the Consortium meeting on July 3, 2017. It was attended by Consortium members and stakeholders from clinical laboratories, industry and academia.

Following a brief introduction to NeuroMET, the symposium included sessions on MRI, cognition and biomarkers, and prompted much discussion between the participants.

Find more details of the presentations below, along with a summary of the project.

 

Session: MRI

Looking back in time: tracing individual brain atrophy in a single time-point MR image
- Rolf Heckemann, MedTechWest, Göteborg

MR Spectroscopy: What is it and what is its importance in AD early diagnosis
- Ariane Fillmer, Physikalisch-Technische Bundesanstalt, Berlin


Session: Cognition

Towards a Metrology of Cognition
- Stefan Cano, Modus Outcomes

Measuring outcomes in Parkinson's disease: The case of the Unified Parkinson's Disease Rating Scale (UPDRS)
- Peter Hagell, School of Health & Society, Kristianstad University


Session: Biomarkers

Gothenburg MCI and dementia studies
- Anders Wallin, MD, Professor of Psychiatry and Neurochemistry, Sahlgrenska Academy

Biomarkers in NeuroMet including immunoassays, PCR and reference methods
- Milena Quaglia, LGC & Carla Divieto, INRIM



Participants of the first NeuroMET mini-symposium